Oesophageal Carcinoma Recruiting Phase 2 Trials for Ifetroban (DB12321)

Also known as: Carcinoma of Esophagus / Esophageal Carcinoma / Carcinoma, Esophageal / Esophagus Carcinoma / Carcinoma of oesophagus NOS / Carcinoma of oesophagus / Oesophageal carcinoma NOS / Esophageal carcinoma NOS

IndicationStatusPhase
DBCOND0032513 (Oesophageal Carcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03694249Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic RecurrenceTreatment